Table 3.
Univariate analysis for disease-free survival (DFS) and overall survival (OS)
Variable | DFS | OS | ||||
---|---|---|---|---|---|---|
|
|
|||||
HR | 95% CI | P value | HR | 95% CI | P value | |
Age, years | ||||||
< 65 | ----- | ----- | ||||
≥ 65 | 1.333 | 0.869-2.045 | 0.188 | 1.354 | 0.883-2.077 | 0.165 |
Gender | ||||||
Male | ----- | ----- | ||||
Female | 0.826 | 0.552-1.235 | 0.352 | 0.829 | 0.555-1.240 | 0.362 |
Location | ||||||
Right | 1.022 | 0.598-1.748 | 0.936 | 1.054 | 0.617-1.803 | 0.846 |
Transverse | 1.192 | 0.528-2.691 | 0.672 | 1.201 | 0.532-2.711 | 0.659 |
Left | 1.301 | 0.576-2.938 | 0.527 | 1.402 | 0.620-3.170 | 0.417 |
Sigmoid colon | 1.053 | 0.632-1.754 | 0.844 | 1.082 | 0.649-1.802 | 0.764 |
Rectum | ----- | ----- | ||||
T stage | ||||||
T1 | 0.086 | 0.120-0.625 | 0.015* | 0.093 | 0.013-0.675 | |
T2 | 0.363 | 0.200-0.660 | 0.001* | 0.370 | 0.204-0.672 | 0.001* |
T3 | 0.460 | 0.296-0.715 | 0.001* | 0.485 | 0.312-0.754 | 0.001* |
T4 | ----- | ----- | ||||
N stage | ||||||
N0 | 0.176 | 0.090-0.346 | < 0.001* | 0.190 | 0.097-0.372 | < 0.001* |
N1 | 0.346 | 0.166-0.721 | 0.005* | 0.355 | 0.171-0.738 | 0.006* |
N2 | ----- | ----- | ||||
M stage | ||||||
M0 | ----- | ----- | ||||
M1 | 3.891 | 2.119-7.145 | < 0.001* | 3.536 | 1.928-6.485 | < 0.001* |
AJCC stage | ||||||
I | 0.126 | 0.058-0.278 | < 0.001* | 0.142 | 0.065-0.311 | < 0.001* |
II | 0.226 | 0.119-0.432 | < 0.001* | 0.259 | 0.136-0.493 | < 0.001* |
III | 0.406 | 0.207-0.798 | 0.009* | 0.441 | 0.225-0.866 | 0.017* |
IV | ----- | ----- | ||||
Differentiation | ||||||
High | 0.889 | 0.469-1.687 | 0.719 | 0.930 | 0.490-1.766 | 0.825 |
Moderate | 0.922 | 0.522-1.631 | 0.781 | 0.966 | 0.546-1.709 | 0.906 |
Low | ----- | ----- | ||||
SERPINA4 | ||||||
Negative | 11.727 | 3.691-37.257 | < 0.001* | 12.268 | 3.858-39.007 | < 0.001* |
Weak | 3.117 | 0.913-10.650 | 0.050* | 3.219 | 0.941-11.010 | 0.042* |
Positive | ----- | ----- |
HR hazard ratio, CI confidence interval.
P < 0.05 indicates that the 95% CI of the HR did not include 1.